Sustained virological response in hepatitis C virus type 1b infected patients is predicted by the number of mutations within the NS5A-ISDR: a meta-analysis focused on geographical differences
Open Access
- 1 September 2004
- Vol. 53 (9) , 1345-1351
- https://doi.org/10.1136/gut.2003.031336
Abstract
Background and aims: There is growing evidence that the response of hepatitis C virus (HCV) genotype 1b infected patients towards interferon (IFN) therapy is influenced by the number of mutations within the carboxy terminal region of the NS5A gene, the interferon sensitivity determining region (ISDR). Patients and methods: In order to attain better insight into this correlation, a file comprising published data on ISDR strains from 1230 HCV genotype 1b infected patients, mainly from Japan and Europe, was constructed and analysed by logistic regression. Sustained virological response (SVR) was defined as negative HCV RNA six months after treatment. Results: The distribution of wild-, intermediate-, and mutant-type ISDR sequences differed significantly between Japanese (n = 655) (44.1%, 37.6%, and 18.3%) and European patients (n = 525) (24.8%, 63.4%, and 11.8%; pv 1.39; pConclusion: These data support the concept that mutant-type ISDR strains may represent a subtype within genotype 1b with a more favourable response towards IFN therapy.Keywords
This publication has 45 references indexed in Scilit:
- Variations within hepatitis C virus E2 protein and response to interferon treatmentVirus Research, 2001
- Number and Position of Mutations in the Interferon (IFN) Sensitivity–Determining Region of the Gene for Nonstructural Protein 5A Correlate with IFN Efficacy in Hepatitis C Virus Genotype 1b InfectionThe Journal of Infectious Diseases, 2001
- Statistical analysis of combined substitutions in nonstructural 5A region of hepatitis C virus and interferon response.2001
- Two PKR inhibitor HCV proteins correlate with early but not sustained response to interferonGastroenterology, 2000
- Mutations in the E2–Pephd and Ns5a Region of Hepatitis C Virus Type 1 and the Dynamics of Hepatitis C Viremia Decline During Interferon Alfa TreatmentHepatology, 2000
- Integrity of the NS5A (amino acid 2209 to 2248) region in hepatitis C virus 1b patients non-responsive to interferon therapyLiver International, 2000
- Prospective Characterization of Full-Length Hepatitis C Virus NS5A Quasispecies during Induction and Combination Antiviral TherapyJournal of Virology, 2000
- The NS5a gene of hepatitis C virus in patients treated with interferon-alpha.2000
- Hepatitis C virus NS5A protein inhibits interferon antiviral activity, but the effects do not correlate with clinical responseGastroenterology, 1999
- Characterization of the Effects of Hepatitis C Virus Nonstructural 5A Protein Expression in Human Cell Lines and on Interferon–Sensitive Virus ReplicationHepatology, 1999